Cargando…
A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension
Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index fo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262313/ https://www.ncbi.nlm.nih.gov/pubmed/35833099 http://dx.doi.org/10.1002/pul2.12102 |
_version_ | 1784742467725164544 |
---|---|
author | Zhai, Ya‐Nan Li, Ai‐Li Tao, Xin‐Cao Xie, Wan‐Mu Gao, Qian Zhang, Yu Chen, Ai‐Hong Lei, Jie‐Ping Zhai, Zhen‐Guo |
author_facet | Zhai, Ya‐Nan Li, Ai‐Li Tao, Xin‐Cao Xie, Wan‐Mu Gao, Qian Zhang, Yu Chen, Ai‐Hong Lei, Jie‐Ping Zhai, Zhen‐Guo |
author_sort | Zhai, Ya‐Nan |
collection | PubMed |
description | Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index for evaluating markedly elevated PVR in chronic thromboembolic pulmonary hypertension (CTEPH). We studied 127 CTEPH patients. We estimated the systolic and mean pulmonary artery pressure using echocardiography (sPAP(Echo), mPAP(Echo)) and measured the left ventricular internal diameter at end diastole (LVIDd). sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd were then correlated with invasive PVR. Using receiver operating characteristic curve analysis, a cutoff value for the index was generated to identify patients with PVR > 1000 dyn·s·cm(−5). We analyzed pre‐ and postoperative hemodynamics and echocardiographic data in 49 patients who underwent pulmonary endarterectomy (PEA). In this study, mPAP(Echo)/LVIDd moderately correlated with PVR (r = 0.51, p < 0.0001). There was a better correlation between PVR and sPAP(Echo)/LVIDd (r = 0.61, p < 0.0001). sPAP(Echo)/LVIDd ≥ 1.94 had an 77.1% sensitivity and 75.4% specificity to determine PVR > 1000 dyn·s·cm(−5) (area under curve = 0.804, p < 0.0001, 95% confidence interval [CI], 0.66–0.90). DeLong's method showed there was a statistically significant difference between sPAP(Echo)/LVIDd with tricuspid regurgitation velocity(2)/velocity–time integral of the right ventricular outflow tract (difference between areas 0.14, 95% CI, 0.00–0.27). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd significantly decreased after PEA (both p < 0.0001). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd reduction rate (ΔsPAP(Echo)/LVIDd and ΔmPAP(Echo)/LVIDd) was significantly correlated with PVR reduction rate (ΔPVR), respectively (r = 0.58, p < 0.01; r = 0.69, p < 0.05). In conclusion, the index of sPAP(Echo)/LVIDd could be a simpler and reliable method in estimating CTEPH with markedly elevated PVR and also be a convenient method of estimating PVR both before and after PEA. |
format | Online Article Text |
id | pubmed-9262313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92623132022-07-12 A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension Zhai, Ya‐Nan Li, Ai‐Li Tao, Xin‐Cao Xie, Wan‐Mu Gao, Qian Zhang, Yu Chen, Ai‐Hong Lei, Jie‐Ping Zhai, Zhen‐Guo Pulm Circ Research Articles Several echocardiographic methods to estimate pulmonary vascular resistance (PVR) have been proposed. So far, most studies have focused on relatively low PVR in patients with a nonspecific type of pulmonary hypertension. We aimed to clarify the clinical usefulness of a new echocardiographic index for evaluating markedly elevated PVR in chronic thromboembolic pulmonary hypertension (CTEPH). We studied 127 CTEPH patients. We estimated the systolic and mean pulmonary artery pressure using echocardiography (sPAP(Echo), mPAP(Echo)) and measured the left ventricular internal diameter at end diastole (LVIDd). sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd were then correlated with invasive PVR. Using receiver operating characteristic curve analysis, a cutoff value for the index was generated to identify patients with PVR > 1000 dyn·s·cm(−5). We analyzed pre‐ and postoperative hemodynamics and echocardiographic data in 49 patients who underwent pulmonary endarterectomy (PEA). In this study, mPAP(Echo)/LVIDd moderately correlated with PVR (r = 0.51, p < 0.0001). There was a better correlation between PVR and sPAP(Echo)/LVIDd (r = 0.61, p < 0.0001). sPAP(Echo)/LVIDd ≥ 1.94 had an 77.1% sensitivity and 75.4% specificity to determine PVR > 1000 dyn·s·cm(−5) (area under curve = 0.804, p < 0.0001, 95% confidence interval [CI], 0.66–0.90). DeLong's method showed there was a statistically significant difference between sPAP(Echo)/LVIDd with tricuspid regurgitation velocity(2)/velocity–time integral of the right ventricular outflow tract (difference between areas 0.14, 95% CI, 0.00–0.27). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd significantly decreased after PEA (both p < 0.0001). The sPAP(Echo)/LVIDd and mPAP(Echo)/LVIDd reduction rate (ΔsPAP(Echo)/LVIDd and ΔmPAP(Echo)/LVIDd) was significantly correlated with PVR reduction rate (ΔPVR), respectively (r = 0.58, p < 0.01; r = 0.69, p < 0.05). In conclusion, the index of sPAP(Echo)/LVIDd could be a simpler and reliable method in estimating CTEPH with markedly elevated PVR and also be a convenient method of estimating PVR both before and after PEA. John Wiley and Sons Inc. 2022-07-01 /pmc/articles/PMC9262313/ /pubmed/35833099 http://dx.doi.org/10.1002/pul2.12102 Text en © 2022 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Zhai, Ya‐Nan Li, Ai‐Li Tao, Xin‐Cao Xie, Wan‐Mu Gao, Qian Zhang, Yu Chen, Ai‐Hong Lei, Jie‐Ping Zhai, Zhen‐Guo A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title | A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title_full | A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title_fullStr | A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title_full_unstemmed | A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title_short | A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
title_sort | simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262313/ https://www.ncbi.nlm.nih.gov/pubmed/35833099 http://dx.doi.org/10.1002/pul2.12102 |
work_keys_str_mv | AT zhaiyanan asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT liaili asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT taoxincao asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT xiewanmu asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT gaoqian asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT zhangyu asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT chenaihong asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT leijieping asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT zhaizhenguo asimplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT zhaiyanan simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT liaili simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT taoxincao simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT xiewanmu simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT gaoqian simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT zhangyu simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT chenaihong simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT leijieping simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension AT zhaizhenguo simplernoninvasivemethodofpredictingmarkedlyelevatedpulmonaryvascularresistanceinpatientswithchronicthromboembolicpulmonaryhypertension |